EyeOnBI.org is part of an effort to return Beth Israel Deaconess to its founding principles and ensure that the administration is putting the interests of patients, workers and community members first. Read more

« Jaffe enters settlement in money laundering case | Main | Investigation of Another Board Member Raises Concerns »

Oversight questions raised about BI docs receiving pharma cash

Dr. Amjad Almahameed, a BI doc who earned $125,600 from GlaxoSmithKline, the third highest among Massachusetts doctors in pharma payments, “may have given talks that were not in compliance” with BI policy according to a BI spokesperson. Another physician from BI was one of five in the state who received money from pharmaceutical companies even though he was disciplined for poor conduct by the Massachusetts Medical Board. There were 62 incident reports filed against him.

October 19, 2010 Prescription for prestige

October 19, 2010 Doctors with questionable records earn a lot as drug firms’ speakers

Eli Lilly Physician Payment Disclosures Freedom of Information Request, Massachusetts Board of Registration in Medicine, April 2010.

References (4)

References allow you to track sources for this article, as well as articles that were written in response to this article.
  • Response
    Some of the question will be seeing in different various things. It deals with the few reason of the different reasons. Every question has a separate answer according to the following reasons. This is known as the dependent of the different questions as well.
  • Response
  • Response
    After reading about article I am also wondering to become a doctor because they are making good money. But still these are much kind of complications that we are not concern about in these kinds of situations.
  • Response

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>